Titan Medical (TSE:TMD) Reaches New 52-Week Low at $0.06

Titan Medical Inc. (TSE:TMD) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as C$0.06 and last traded at C$0.06, with a volume of 82195 shares. The stock had previously closed at C$0.06.

Titan Medical Stock Performance

The stock’s 50-day moving average is C$0.08 and its 200 day moving average is C$0.09. The stock has a market cap of C$6.77 million, a price-to-earnings ratio of -1.50 and a beta of 2.03. The company has a debt-to-equity ratio of 19.07, a current ratio of 4.92 and a quick ratio of 1.18.

Titan Medical (TSE:TMD) last posted its quarterly earnings results on Monday, April 1st. The company reported C($0.04) EPS for the quarter. Titan Medical had a negative net margin of 10.93% and a negative return on equity of 24.94%. As a group, analysts predict that Titan Medical Inc. will post -1.9800001 earnings per share for the current fiscal year.

Titan Medical Company Profile

Titan Medical Inc, a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures.